Explore
Search ClinicalTrials.gov
Find trials by condition, intervention, sponsor, or location. Filter by status, phase, and study type — or enter an NCT ID to jump straight to a trial.
Results for “AstraZeneca”
Sponsor: ARCAGY/ GINECO GROUP
Epithelial Ovarian Cancer · Peritoneal Cancer · Fallopian Tube Cancer
France
Sponsor: University of Nebraska
Lung Cancer · Carcinoma, Non-Small Cell Lung
United States
Sponsor: AstraZeneca
Systemic Lupus Erythematosus
Sponsor: Maastricht University Medical Center
Non-Small Cell Lung Cancer
Netherlands
- A Study of Osimertinib With or Without Chemotherapy Versus Chemotherapy Alone as Neoadjuvant Therapy for Patients With EGFRm Positive Resectable Non-Small Cell Lung CancerActive Not Recruiting
Sponsor: AstraZeneca
Non-Small Cell Lung Cancer
United States, Austria, Brazil, Bulgaria, Canada +20 more
- A Study on Limiting Treatment Time With Acalabrutinib Combined With Obinutuzumab in People With CLL or SLLActive Not Recruiting
Sponsor: Memorial Sloan Kettering Cancer Center
Chronic Lymphocytic Leukemia · Small Lymphocytic Lymphoma
United States
Sponsor: AstraZeneca
Non-small Cell Lung Cancer
Australia
- Tezepelumab (Tezspire) Regulatory Postmarketing Surveillance in KoreaNot Yet Recruiting
Sponsor: AstraZeneca
Severe Asthma · Chronic Rhinosinusitis With Nasal Polyps(CRSwNP)
Sponsor: AstraZeneca
Systemic Lupus Erythematosus (SLE)
Spain
Sponsor: AstraZeneca
Muscle Invasive Bladder Cancer
United States, Argentina, Austria, Brazil, Canada +20 more
- A Study to Investigate the Effect of AZD0780 Tablets in Combination With Rosuvastatin Tablets on Low Density Lipoprotein Cholesterol Levels (LDL-C) in Adult Participants With DyslipidaemiaActive Not Recruiting
Sponsor: AstraZeneca
Dyslipidaemia
Russia
Sponsor: AstraZeneca
Hereditary Transthyretin Amyloidosis · Carpal Tunnel Syndrome · Polyneuropathy · Amyloidosis
Russia
Sponsor: Stanford University
Lung Cancer
United States
Sponsor: AstraZeneca
Obesity or Overweight
United States, Australia, Canada, Germany, Japan
- A Phase III Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With CKD Stage 3b and 4 (BalanceD-CKD)Not Yet Recruiting
Sponsor: AstraZeneca
Renal Insufficiency, Chronic
Argentina, Canada, Germany, Japan, Poland +3 more
Sponsor: European Organisation for Research and Treatment of Cancer - EORTC
NSCLC
Belgium, France, Jordan, Poland, Slovenia +1 more
- Multinational Observational Study to Describe Diagnostic Stage Shift in Patients With Lung Cancer Using Medical RecordsNot Yet Recruiting
Sponsor: AstraZeneca
Lung Cancer
Sponsor: Takeda
Multiple System Atrophy
United States, Austria, Denmark, France, Germany +5 more
Sponsor: AstraZeneca
COPD
China
- Small/Middle Tier Cities and County Lung Cancer Quality Improvement Project (QIP) StudyActive Not Recruiting
Sponsor: AstraZeneca
Carcinoma, Non-Small-Cell Lung · Lung Neoplasms · Respiratory Tract Neoplasms · Thoracic Neoplasms
China
Sponsor: AstraZeneca
Metastatic Castration-resistant Prostate Cancer
France
Sponsor: National and Kapodistrian University of Athens
Antiphospholipid Syndrome (APS)
Greece
Sponsor: AstraZeneca
Chronic Lymphocytic Leukemia, CLL
United Kingdom
- Abiraterone/Prednisone, Olaparib, or Abiraterone/Prednisone + Olaparib in Patients With Metastatic Castration-Resistant Prostate Cancer With DNA Repair DefectsActive Not Recruiting
Sponsor: Northwestern University
Prostate Cancer Metastatic Castration-Resistant · Abnormal DNA Repair · Metastatic Prostate Carcinoma · Stage IV Prostate Cancer
United States
- A Phase III Study to Assess the Effect of FDC Laroprovstat/Rosuvastatin Compared With Laroprovstat, Rosuvastatin and Placebo on LDL-C in LLT-naïve Patients.Not Yet Recruiting
Sponsor: AstraZeneca
Hypercholesterolaemia